Previous Close | 221.50 |
Open | 219.50 |
Bid | 213.00 x 0 |
Ask | 214.00 x 0 |
Day's Range | 211.00 - 219.50 |
52 Week Range | 164.00 - 302.00 |
Volume | |
Avg. Volume | 17,536 |
Market Cap | 5.116B |
Beta (5Y Monthly) | 1.23 |
PE Ratio (TTM) | 34.10 |
EPS (TTM) | 6.29 |
Earnings Date | Feb 06, 2025 |
Forward Dividend & Yield | 2.25 (1.02%) |
Ex-Dividend Date | May 06, 2024 |
1y Target Est | 270.00 |
CellaVision AB (CLVSF) reports a 9% organic growth and improved gross margins, despite facing headwinds in the Americas and China.
As global markets navigate shifting economic landscapes, the Swedish market has been influenced by recent monetary policy adjustments from the European Central Bank, which have sparked optimism for further easing. In this context of potential economic support, identifying undervalued stocks can be a strategic move for investors seeking opportunities in Sweden's evolving financial environment.